634 related articles for article (PubMed ID: 31247468)
1. Research progress in the relationship between type 2 diabetes mellitus and intestinal flora.
Ma Q; Li Y; Li P; Wang M; Wang J; Tang Z; Wang T; Luo L; Wang C; Wang T; Zhao B
Biomed Pharmacother; 2019 Sep; 117():109138. PubMed ID: 31247468
[TBL] [Abstract][Full Text] [Related]
2. Will intestinal flora therapy become a new target in type-2 diabetes mellitus? A review based on 13 clinical trials.
Wang F; Zhao T; Wang W; Dai Q; Ma X
Nutr Hosp; 2022 Mar; 39(2):425-433. PubMed ID: 34844413
[TBL] [Abstract][Full Text] [Related]
3. Effects of probiotics on glycemic control and intestinal dominant flora in patients with type 2 diabetes mellitus: A protocol for systematic review and meta-analysis.
Sun Y; Huang Y; Ye F; Liu W; Jin X; Lin K; Wang J; Gao Y; He L
Medicine (Baltimore); 2020 Nov; 99(46):e23039. PubMed ID: 33181668
[TBL] [Abstract][Full Text] [Related]
4. Relationship between gut microbiota, probiotics, and type 2 diabetes mellitus.
Salgaço MK; Oliveira LGS; Costa GN; Bianchi F; Sivieri K
Appl Microbiol Biotechnol; 2019 Dec; 103(23-24):9229-9238. PubMed ID: 31664483
[TBL] [Abstract][Full Text] [Related]
5. Comparative analysis of the intestinal flora in type 2 diabetes and nondiabetic mice.
Horie M; Miura T; Hirakata S; Hosoyama A; Sugino S; Umeno A; Murotomi K; Yoshida Y; Koike T
Exp Anim; 2017 Oct; 66(4):405-416. PubMed ID: 28701620
[TBL] [Abstract][Full Text] [Related]
6. Translational research into gut microbiota: new horizons on obesity treatment: updated 2014.
Tsukumo DM; Carvalho BM; Carvalho Filho MA; Saad MJ
Arch Endocrinol Metab; 2015 Apr; 59(2):154-60. PubMed ID: 25993679
[TBL] [Abstract][Full Text] [Related]
7. Gut microbiota: A new target for T2DM prevention and treatment.
Liu L; Zhang J; Cheng Y; Zhu M; Xiao Z; Ruan G; Wei Y
Front Endocrinol (Lausanne); 2022; 13():958218. PubMed ID: 36034447
[TBL] [Abstract][Full Text] [Related]
8. Targeting gut microbiota as a possible therapy for diabetes.
He C; Shan Y; Song W
Nutr Res; 2015 May; 35(5):361-7. PubMed ID: 25818484
[TBL] [Abstract][Full Text] [Related]
9. Intestinal Microbiota in Type 2 Diabetes and Chronic Kidney Disease.
Sabatino A; Regolisti G; Cosola C; Gesualdo L; Fiaccadori E
Curr Diab Rep; 2017 Mar; 17(3):16. PubMed ID: 28271466
[TBL] [Abstract][Full Text] [Related]
10. Regulation of the intestinal flora: A potential mechanism of natural medicines in the treatment of type 2 diabetes mellitus.
He L; Yang FQ; Tang P; Gao TH; Yang CX; Tan L; Yue P; Hua YN; Liu SJ; Guo JL
Biomed Pharmacother; 2022 Jul; 151():113091. PubMed ID: 35576662
[TBL] [Abstract][Full Text] [Related]
11. Prevention and treatment strategies for type 2 diabetes based on regulating intestinal flora.
Xie D; Zhao X; Chen M
Biosci Trends; 2021 Nov; 15(5):313-320. PubMed ID: 34565781
[TBL] [Abstract][Full Text] [Related]
12. Role of the Gut Microbiome in the Pathogenesis of Obesity and Obesity-Related Metabolic Dysfunction.
Bouter KE; van Raalte DH; Groen AK; Nieuwdorp M
Gastroenterology; 2017 May; 152(7):1671-1678. PubMed ID: 28192102
[TBL] [Abstract][Full Text] [Related]
13. Intestinal microbiota and type 2 diabetes: from mechanism insights to therapeutic perspective.
Han JL; Lin HL
World J Gastroenterol; 2014 Dec; 20(47):17737-45. PubMed ID: 25548472
[TBL] [Abstract][Full Text] [Related]
14. Role of gut microbiota in obesity, type 2 diabetes and Alzheimer's disease.
Naseer MI; Bibi F; Alqahtani MH; Chaudhary AG; Azhar EI; Kamal MA; Yasir M
CNS Neurol Disord Drug Targets; 2014 Mar; 13(2):305-11. PubMed ID: 24059313
[TBL] [Abstract][Full Text] [Related]
15. Could the beneficial effects of dietary calcium on obesity and diabetes control be mediated by changes in intestinal microbiota and integrity?
Gomes JM; Costa JA; Alfenas RC
Br J Nutr; 2015 Dec; 114(11):1756-65. PubMed ID: 26400630
[TBL] [Abstract][Full Text] [Related]
16. Impacts of Plant-derived Secondary Metabolites for Improving Flora in Type 2 Diabetes.
Li LZ; Yan Y; Song Q; Wang Z; Zhang W; Hou Y; Zhang X
Curr Diabetes Rev; 2023; 19(7):e160123212750. PubMed ID: 36650624
[TBL] [Abstract][Full Text] [Related]
17. Gut microbiome: New perspectives for type 2 diabetes prevention and treatment.
Li SX; Guo Y
World J Clin Cases; 2023 Nov; 11(31):7508-7520. PubMed ID: 38078135
[TBL] [Abstract][Full Text] [Related]
18. Comparison of gut microbiota in adult patients with type 2 diabetes and healthy individuals.
Sedighi M; Razavi S; Navab-Moghadam F; Khamseh ME; Alaei-Shahmiri F; Mehrtash A; Amirmozafari N
Microb Pathog; 2017 Oct; 111():362-369. PubMed ID: 28912092
[TBL] [Abstract][Full Text] [Related]
19. Gut Microbiota and Energy Expenditure in Health and Obesity.
Bakker GJ; Zhao J; Herrema H; Nieuwdorp M
J Clin Gastroenterol; 2015; 49 Suppl 1():S13-9. PubMed ID: 26447957
[TBL] [Abstract][Full Text] [Related]
20. [Microbiome, diabetes and heart: a novel link?].
Kappel BA; Lehrke M
Herz; 2019 May; 44(3):223-230. PubMed ID: 30847506
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
